Inclaudamab - ACC
-
Igår fik vi så lidt mere smag på Inclacumab.
fra 2.50 cirka.
We have a new target! It appears it really makes a difference. Concern about safety!
Lige på grænsen af p 0.05.
Vi skal have et større forsøg.
http://www.cardiosource.org/News-Media/Cardiosource-Video-News.aspx?vidid=w59UKuQTlkO6LWftXyS-KA
Late-Breaking Clinical Trials III: Chronic CAD/Stable Ischemic Heart Disease and Acute Coronary Syndromes
Session 302
Sunday, March 10, 10:45 a.m. - 12:15 p.m.
South, Esplanade BallroomThe STREAM Trial
Early Administration of Eplerenone in Patients with Acute Myocardial Infarction Without Heart Failure: Results of the Randomized, Double-Blind, Placebo-Controlled REMINDER Trial
Effects of the P-Selectin Antagonist Inclacumab in the Select-Acute Coronary Syndromes Trial
Randomized Comparison of High-dose Oral Vitamins vs. Placebo in the Trial to Assess Chelation Therapy
Evaluation of Ranolazine in Patients with Type 2 Diabetes Mellitus and Chronic Stable Angina: Results from the Type 2 Diabetes Evaluation of Ranolazine in Subjects with Chronic Stable Angina (TERISA) randomized clinical trial -
og her link fra Chat
http://www.theheart.org/article/1516411.do
He continued: ''This is still a pilot study with fewer than 600 patients-getting something definitive will take a much larger study. This, however, is the kind of study we should be doing: rationally based and scientific developed. This looks very promising, and I hope we get to see this in larger trials."
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind